Inventor · disambiguated record
Chih-Hsiang Leng
Also filed as: LENG CHIH-HSIANG
18 granted patents·5 pending applications·42 citations·filing 2008–2021
91Inventor score
Files withLENG CHIH-HSIANG4NAT HEALTH RESEARCH INSTITUTES4NATIONAL HEALTH RES INST3KEMYTH BIOTECH CO LTD2LIU SHIH-JEN2
Top patents by PatentIndex Score
23 records- 0191US7833776B2Lipidating sequences and use thereof for producing lipidated proteins in E. coliNAT HEALTH RESEARCH INSTITUTES·Filed 2008·Granted Nov 16, 2010·9 cites·16 claims
- 0290US10406221B2Lipidated Streptococcus pneumoniae antigen compositions, methods of preparation and useNAT RES COUNCIL CANADA·Filed 2017·Granted Sep 10, 2019·5 cites·25 claims
- 0386US10172945B2Sorbitan polyester conjugates for stabilizing water-in-oil emulsions and delivering controlled release of bioactive agentsNATIONAL HEALTH RES INST·Filed 2016·Granted Jan 8, 2019·4 cites·20 claims
- 0485US8465756B2Immunogenic peptides of tumor associated antigen L6 and uses thereof in cancer therapyLIU SHIH-JEN·Filed 2010·Granted Jun 18, 2013·5 cites·8 claims
- 0581US8771990B2Method of producing lipidated polypeptidesLENG CHIH-HSIANG·Filed 2011·Granted Jul 8, 2014·4 cites·12 claims
- 0680US8466259B2AdjuvantsLIU SHIH-JEN·Filed 2010·Granted Jun 18, 2013·5 cites·14 claims
- 0780US8444993B2Multi-phase emulsions based on amphiphilic block copolymersHUANG MING-HSI·Filed 2012·Granted May 21, 2013·6 cites·18 claims
- 0870US8658767B2Lipidated polyepitope vaccinesLENG CHIH-HSIANG·Filed 2011·Granted Feb 25, 2014·2 cites·9 claims
- 0962US9493518B2Compositions and methods for treating clostridium difficile-associated diseasesNAT HEALTH RESEARCH INSTITUTES·Filed 2014·Granted Nov 15, 2016·0 cites·8 claims
- 1059US11266728B2Compositions and methods for enhancement of immune responsesNATIONAL HEALTH RES INST·Filed 2017·Granted Mar 8, 2022·0 cites·12 claims
- 1159US8716512B2Preparation and purification of subunit vaccine for Neisseria meningitidis (NM) group B isolatesHSIEH SHIH-YANG·Filed 2011·Granted May 6, 2014·2 cites·20 claims
- 1259US2011052633A1Multi-phase emulsions based on amphiphilic block copolymersNAT HEALTH RESEARCH INSTITUTES·Filed 2009·Application pending·0 cites
- 1357US7981431B2Consensus dengue virus envelope protein domain III polypeptides (cED III) and their methods of useNAT HEALTH RESEARCH INSTITUTES·Filed 2008·Granted Jul 19, 2011·0 cites·17 claims
- 1455US10995126B2Immunogenic peptide containing a b cell epitope of tumor associated antigen L6NATIONAL HEALTH RES INST·Filed 2017·Granted May 4, 2021·0 cites·17 claims
- 1554US8426163B2Production of lipidated proteins in E. coliLENG CHIH-HSIANG·Filed 2008·Granted Apr 23, 2013·0 cites·6 claims
- 1649US8658176B2Lipidated tumor-associated antigens and immunotherapeutic compositionsLENG CHIH-HSIANG·Filed 2010·Granted Feb 25, 2014·0 cites·22 claims
- 1747US11904013B2Immunogenic composition and use thereofADIMMUNE CORP·Filed 2021·Granted Feb 20, 2024·0 cites·15 claims
- 1846US8287880B2Lipidated vaccine against dengue virus infectionCHEN HSIN-WEI·Filed 2010·Granted Oct 16, 2012·0 cites·19 claims
- 1946US2018360943A1Lipidated streptococcus pneumoniae antigen compositions, methods of preparation and useNAT RES COUNCIL CANADA·Filed 2016·Application pending·0 cites
- 2041US2009205977A1Method and system for detecting a target with a specific markerSHEW BOR-YUAN·Filed 2008·Application pending·0 cites
- 2140US10287328B2Treatment of diabetes, toll-like receptor 4 modulators and methods for using the sameKEMYTH BIOTECH CO LTD·Filed 2017·Granted May 14, 2019·0 cites·19 claims
- 2239US2019359658A1Treatment of diabetes, toll-like receptor 4 modulators and methods for using the sameKEMYTH BIOTECH CO LTD·Filed 2019·Application pending·0 cites
- 2338US2013251748A1Use of outer membrane porin k36 protein (ompk36) in treatment/prevention/diagnosis of enterobacteriaceae infectionSIU LEUNG-KEI·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Chih-Hsiang Leng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →